Fig. 1

The comparison of β2ADR (a), COX-1 (b), COX-2 (c) IL-1β (d), IL-6 (e), IL-10 (f), and TNF-α (g) mRNA expressions between control and treated groups. 1) Beta-2 adrenergic receptor, 2) Cyclooxygenases-1, 3) Cyclooxygenases-2, 4) Interleukin-1β, 5) Interleukin − 6, 6) Interleukin − 10, and 7) Tumor necrosis factor-α. β2ADR, COX-1, COX-2, IL-1β, IL-6, IL-10, and TNF-α mRNA data that  were normalized by β-actin. (BAA) Beta-2 adrenergic agonist (Salmeterol, 1 mg/kg live BW) and (BB) Beta blocker (Propranolol, 2 mg/kg live BW), Different statistical letters (a-c) are significant (p < 0.05) according to the Duncan’s multiple range test